ADAR1 Capital Management »

Arvinas Ord shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Arvinas Ord (ARVN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Arvinas Ord

Tip: Access up to 7 years of quarterly data

All positions including Arvinas Ord held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arvinas Ord by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 26k 41.28
2023-12-31 $33k 800 41.16

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Arvinas Ord

EcoR1 Capital
Vanguard Group
BlackRock
BlackRock
T. Rowe Price Associates
Citadel Advisors
Bellevue Group
Paradigm Biocapital Advisors
Jpmorgan Chase & Co
State Street Corporation
Geode Capital Management
Avidity Partners Management
Nextech Invest
Braidwell
Opaleye Management

View all funds holding Arvinas Ord